Vedolizumab subcutaneous injection

( DrugBank: Vedolizumab / KEGG DRUG: Vedolizumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	30

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	61

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 10 of 30 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2022-000837-17-NL (EUCTR)	07/12/2022	29/09/2022	Lengthening of vedolizumab injections based on drug concentrations in patients with inflammatory bow ...	Subcutaneous vedolizumabdrug de-escalation using therapeutic drug monitoring in inflammatory bowel d ...	Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - D ...	Trade Name: Vedolizumab, Entyvio	Amsterdam UMC	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	40	Phase 4	Netherlands
2	EUCTR2015-000481-58-NL (EUCTR)	14/07/2016	15/02/2016	Effectiveness and Safety of Vedolizumab SC as Maintenance Therapy in Crohn’s Disease	A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Entyvio Product Name: VedolizumabIV Product Code: MLN0002 INN or Proposed INN: Vedolizumab O ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	824	Phase 3	United States;Serbia;Taiwan;Estonia;Slovakia;Spain;Ukraine;Israel;Russian Federation;Italy;Denmark;A ...
3	EUCTR2015-000481-58-BE (EUCTR)	30/06/2016	14/03/2016	Effectiveness and Safety of Vedolizumab SC as Maintenance Therapy in Crohn’s Disease	A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Entyvio Product Name: VedolizumabIV Product Code: MLN0002 INN or Proposed INN: Vedolizumab O ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	824	Phase 3	Russian Federation;United States;Netherlands;Sweden;Brazil;Korea, Republic of;Poland;Slovakia;Bulgar ...
4	EUCTR2015-000482-31-BE (EUCTR)	30/06/2016	14/03/2016	Long-term effectiveness and Safety of VedolizumabSC as a Therapy for Ulcerative Colitis and Crohn's ...	A Phase 3b Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab Subcutaneo ...	Ulcerative ColitisCrohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: ...	Product Name: Vedolizumab SC Product Code: MLN0002 SC INN or Proposed INN: Vedolizumab SC	Takeda Development Centre Europe, Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	692	Phase 3	Serbia;United States;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy;Austral ...
5	EUCTR2015-000481-58-DE (EUCTR)	14/06/2016	09/03/2016	Effectiveness and Safety of Vedolizumab SC as Maintenance Therapy in Crohn’s Disease	A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Entyvio Product Name: VedolizumabIV Product Code: MLN0002 INN or Proposed INN: Vedolizumab O ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	824	Phase 3	Serbia;United States;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Italy;Australia ...
6	EUCTR2015-000482-31-HR (EUCTR)	13/06/2016	06/07/2016	Long-term effectiveness and Safety of VedolizumabSC as a Therapy for Ulcerative Colitis and Crohn's ...	A Phase 3b Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab Subcutaneo ...	Ulcerative ColitisCrohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: ...	Product Name: VedolizumabSC Product Code: MLN0002 SC INN or Proposed INN: VedolizumabSC Trade Name: Ent ...	Takeda Development Centre Europe, Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	692	Phase 3	United States;Serbia;Estonia;Slovakia;Spain;Ukraine;Israel;Russian Federation;Colombia;Italy;Denmark ...
7	EUCTR2015-000482-31-RO (EUCTR)	02/06/2016	22/06/2016	Long-term effectiveness and Safety of VedolizumabSC as a Therapy for Ulcerative Colitis and Crohn's ...	A Phase 3b Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab Subcutaneo ...	Ulcerative ColitisCrohn’s Disease MedDRA version: 19.0;Level: PT;Classification code 10011401;Term: ...	Product Name: Vedolizumab SC Product Code: MLN0002 SC INN or Proposed INN: Vedolizumab SC	Takeda Development Centre Europe, Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	692	Phase 3	United States;Serbia;Estonia;Slovakia;Spain;Ukraine;Chile;Israel;Russian Federation;Italy;France;Den ...
8	EUCTR2015-000481-58-DK (EUCTR)	31/05/2016	17/03/2016	Effectiveness and Safety of Vedolizumab SC as Maintenance Therapy in Crohn’s Disease	A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Entyvio Product Name: VedolizumabIV Product Code: MLN0002 INN or Proposed INN: Vedolizumab O ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	824	Phase 3	Serbia;United States;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Italy;Australia ...
9	EUCTR2015-000482-31-DK (EUCTR)	31/05/2016	17/03/2016	Long-term effectiveness and Safety of VedolizumabSC as a Therapy for Ulcerative Colitis and Crohn's ...	A Phase 3b Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab Subcutaneo ...	Ulcerative ColitisCrohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: ...	Product Name: Vedolizumab SC Product Code: MLN0002 SC INN or Proposed INN: Vedolizumab SC	Takeda Development Centre Europe, Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	692	Phase 3	Serbia;United States;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy;Austral ...
10	EUCTR2015-000481-58-ES (EUCTR)	29/05/2016	20/04/2016	Effectiveness and Safety of Vedolizumab SC as Maintenance Therapy in Crohn s Disease	A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Crohn s Disease MedDRA version: 19.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: Entyvio Product Name: VedolizumabIV Product Code: MLN0002 INN or Proposed INN: Vedolizumab O ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	824	Phase 3	Serbia;United States;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Chile;Israel;Italy;France;Aus ...

First Previous1 2 3Next Last

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 61 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2022-000837-17-NL (EUCTR)	07/12/2022	29/09/2022	Lengthening of vedolizumab injections based on drug concentrations in patients with inflammatory bow ...	Subcutaneous vedolizumabdrug de-escalation using therapeutic drug monitoring in inflammatory bowel d ...	Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - D ...	Trade Name: Vedolizumab, Entyvio	Amsterdam UMC	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	40	Phase 4	Netherlands
2	EUCTR2019-001653-99-BE (EUCTR)	26/02/2021	26/02/2021	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	Spain;Ukraine;Russian Federation;Switzerland;Italy;India;France;Malaysia;Australia;Denmark;South Afr ...
3	EUCTR2019-001653-99-LT (EUCTR)	01/02/2021	23/09/2020	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	Italy;India;France;Malaysia;Denmark;Australia;South Africa;Latvia;Netherlands;Korea, Republic of;Tur ...
4	EUCTR2019-001653-99-LV (EUCTR)	18/01/2021	26/10/2020	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	United States;Serbia;Portugal;Slovakia;Spain;Ukraine;Russian Federation;Switzerland;Italy;India;Fran ...
5	EUCTR2019-001653-99-AT (EUCTR)	12/01/2021	24/11/2020	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	United States;Serbia;Portugal;Slovakia;Spain;Ukraine;Russian Federation;Switzerland;Italy;India;Fran ...
6	EUCTR2019-001653-99-DE (EUCTR)	08/01/2021	05/10/2020	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	Portugal;Serbia;United States;Slovakia;Spain;Ukraine;Russian Federation;Switzerland;Italy;India;Fran ...
7	EUCTR2019-001653-99-FR (EUCTR)	26/11/2020	12/10/2020	A placebo-controlled study of mirikizumab and vedolizumabin participants withmoderately to severely ...	A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-Controlled Treat-Through Stu ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: mirikizumab Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	1100	Phase 3	Malaysia;Denmark;United States;Serbia;Portugal;Slovakia;Spain;Ukraine;Russian Federation;Switzerland ...
8	EUCTR2018-001605-93-RO (EUCTR)	10/10/2019	15/03/2022	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	900	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
9	EUCTR2018-001605-93-BG (EUCTR)	09/10/2019	20/09/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
10	EUCTR2018-001605-93-BE (EUCTR)	23/09/2019	07/06/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	AstraZeneca AB	NULL	Not Recruiting	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Italy;Switzerland;India;France;Malaysi ...

First Previous1 2 3 4 5 6 7Next Last